Sylvie Ryckebusch assists life sciences companies with business development strategy and implementation.
Sylvie has 12 years of business development experience within Serono International and Merck Serono where she occupied various senior roles within Business Development and Alliance Management. She has been involved in hundreds of product license discussions and has concluded dozens of transactions. Prior to establishing her consulting practice, Sylvie worked within the Index Ventures Life Sciences team. She completed a PhD in neurosciences at the California Institute of Technology and a postdoctoral fellowship at the Harvard Business School. She went on to spend 4 years as a strategy consultant with Mckinsey and Company.
While at Merck Serono, Sylvie worked with the current Esperare team to create the Foundation. She now provides business development and licensing support to Esperare.
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.